+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone



Surface modifications of influenza proteins upon virus inactivation by β-propiolactone



Proteomics 13(23-24): 3537-3547



Inactivation of intact influenza viruses using formaldehyde or β-propiolactone (BPL) is essential for vaccine production and safety. The extent of chemical modifications of such reagents on viral proteins needs to be extensively investigated to better control the reactions and quality of vaccines. We have evaluated the effect of BPL inactivation on two candidate re-assortant vaccines (NIBRG-121xp and NYMC-X181A) derived from A/California/07/2009 pandemic influenza viruses using high-resolution FT-ICR MS-based proteomic approaches. We report here an ultra performance LC MS/MS method for determining full-length protein sequences of hemagglutinin and neuraminidase through protein delipidation, various enzymatic digestions, and subsequent mass spectrometric analyses of the proteolytic peptides. We also demonstrate the ability to reliably identify hundreds of unique sites modified by propiolactone on the surface of glycoprotein antigens. The location of these modifications correlated with changes to protein folding, conformation, and stability, but demonstrated no effect on protein disulfide linkages. In some cases, these modifications resulted in suppression of protein function, an effect that correlated with the degree of change of the modified amino acids' side chain length and polarity.

(PDF emailed within 0-6 h: $19.90)

Accession: 056023825

Download citation: RISBibTeXText

PMID: 24123778

DOI: 10.1002/pmic.201300096


Related references

Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone. Vaccine 9(6): 398-402, 1991

Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus. Journal of Virological Methods 235: 105-111, 2016

Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11(3): 343-348, 1993

The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors. Egyptian Journal of Immunology 11(2): 9-20, 2006

Curve of inactivation of the aphthous virus with beta-propiolactone. Comparison with other inactivation agents. Annales de L'institut Pasteur 112(2): 145-152, 1967

Inactivation of Newcastle disease virus with propiolactone. Studies of inactivation conditions (concentration, temperature and time). Lucrarile Institutului de Cercetari Veterinare si Biopreparate ' Pasteur' 9: 167-177, 1973

Investigations of the use of beta-propiolactone in virus inactivation In Inactivation of viruses. 1960

Investigations of the use of beta-propiolactone in virus inactivation. Annals of the New York Academy of Sciences 83: 578-594, 1960

Oncogenicity of simian virus and its inactivation with beta-propiolactone. FED PROC 22(2 Pt 1): 438, 1963

Inactivation of the vacuolating virus (SV40) with beta-propiolactone. Rivista Dell'istituto Sieroterapico Italiano 41(1): 7-10, 1966

Inactivation of Newcastle disease virus by beta-propiolactone. Archives of Virology 52(1-2): 175-179, 1976

Further research on the inactivation of poliomyelitis virus by beta-propiolactone. Rivista Dell'istituto Sieroterapico Italiano 31(6): 464-468, 1956

Inactivation of nanb hepatitis virus in iv immunoglobulin using beta propiolactone. 1988

Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone. Beitrage Zur Infusionstherapie 21: 202-204, 1988